Cibc Asset Management Inc Grifols Sa Transaction History

Cibc Asset Management Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 30, 2020	SELL	$16.28 - $25.63 $1.07 Million - $1.68 Million	-65,670 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$19.57 - $23.52 $5,871 - $7,056	300 Added 0.46%	65,670 $1.53 Million
Q3 2019 Oct 30, 2019	SELL	$19.85 - $22.76 $140,637 - $161,254	-7,085 Reduced 9.78%	65,370 $1.31 Million
Q2 2019 Aug 05, 2019	SELL	$17.59 - $21.1 $2.44 Million - $2.92 Million	-138,526 Reduced 65.66%	72,455 $1.53 Million
Q1 2019 May 06, 2019	BUY	$18.01 - $20.11 $1.68 Million - $1.88 Million	93,510 Added 79.6%	210,981 $4.24 Million
Q4 2018 Feb 12, 2019	SELL	$17.44 - $21.53 $21,294 - $26,288	-1,221 Reduced 1.03%	117,471 $2.16 Million
Q3 2018 Nov 02, 2018	SELL	$19.97 - $21.96 $244,073 - $268,395	-12,222 Reduced 9.34%	118,692 $2.54 Million
Q2 2018 Aug 09, 2018	BUY	$20.16 - $24.68 $286,130 - $350,283	14,193 Added 12.16%	130,914 $2.81 Million
Q1 2018 Apr 30, 2018	SELL	$20.31 - $24.95 $11,109 - $13,647	-547 Reduced 0.47%	116,721 $2.48 Million
Q4 2017 Feb 02, 2018	BUY	$20.99 - $23.89 $1.11 Million - $1.27 Million	53,076 Added 82.68%	117,268 $2.69 Million
Q3 2017 Nov 06, 2017	BUY	$20.07 - $21.89 $1.29 Million - $1.41 Million	64,192	64,192 $1.41 Million

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.